🔗 Share this article

The prestigious award in Physiology or Medicine was granted for revolutionary findings that clarify how the body's defense network targets dangerous infections while sparing the healthy tissues.

A trio of renowned researchers—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—received this accolade.

The work uncovered unique "sentinels" within the defense system that remove rogue immune cells that could attacking the organism.

These discoveries are now paving the way for innovative treatments for autoimmune diseases and cancer.

These laureates will share a prize fund worth 11 million SEK.

Decisive Findings

"The work has been essential for understanding how the immune system operates and the reason we don't all develop severe self-attack conditions," commented the head of the award panel.

The team's research explain a core question: How does the defense system protect us from countless infections while leaving our healthy cells unharmed?

Our body's protection system employs immune cells that scan for signs of infection, even viruses and germs it has never encountered.

These defenders employ sensors—known as recognition units—that are generated by chance in a vast number of variations.

That provides the immune system the capacity to combat a wide array of invaders, but the unpredictability of the process inevitably produces white blood cells that may target the body.

Security Guards of the Immune System

Scientists previously understood that a portion of these problematic defense cells were destroyed in the thymus—where white blood cells mature.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—described as the body's "peacekeepers"—which travel through the body to neutralize any defenders that assault the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and RA.

The prize committee stated, "The findings have established a new field of research and spurred the development of innovative therapies, for example for tumors and autoimmune diseases."

Regarding malignancies, T-regs block the system from fighting the growth, so research are focused on lowering their numbers.

In self-attack disorders, experiments are testing increasing T-reg cells so the organism is not being harmed. A comparable method could also be useful in reducing the chances of organ transplant failure.

Innovative Experiments

Professor Sakaguchi, of a Japanese institution, performed tests on mice that had their thymus removed, causing autoimmune disease.

He showed that introducing immune cells from healthy mice could prevent the illness—suggesting there was a system for preventing defenders from attacking the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an genetic autoimmune disease in rodents and humans that led to the identification of a genetic factor critical for the way regulatory T-cells operate.

"The groundbreaking research has uncovered how the body's defenses is controlled by T-reg cells, stopping it from mistakenly targeting the healthy cells," said a prominent biological science expert.

"The research is a remarkable illustration of how fundamental physiological study can have far-reaching consequences for public health."